Serpine2-flox Mouse
一般名
Serpine2-flox
製品ID
S-CKO-05210
背景情報
C57BL/6JCya
系統ID
CKOCMP-20720-Serpine2-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Serpine2-flox Mouse(カタログ番号S-CKO-05210)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Serpine2-flox
系統ID
CKOCMP-20720-Serpine2-B6J-VA
遺伝子名
製品ID
S-CKO-05210
遺伝子別名
B230326M24Rik, PAI-1, PI-7, PI7, PN-1, Spi4
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 1
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000027467
NCBIトランスクリプトID
NM_009255
ターゲット領域
Exon 5
有効領域の大きさ
~1.9 kb
遺伝子研究の概要
Serpine2, also known as Protease Nexin-1, is a serine proteinase inhibitor. Its target specificity can be influenced by extracellular matrix components. It has variable expression in many organs during development, adult stages, pathological situations or after injury. Genetically modified mice serve as useful in vivo models to study its functions [4].
In cancer research, Serpine2 knockdown has been shown to improve tumor radiosensitivity in lung cancer, as it reduces homologous recombination repair, suppresses cell migration and invasion, and inhibits the accumulation of p-ATM and RAD51 during DNA repair [1]. In liver cancer, SERPINE2 promotes metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation, and its knockdown enhances the efficacy of sorafenib and lenvatinib [2]. In advanced renal cell carcinoma, SERPINE2 knockdown suppresses cell growth and invasion, while overexpression promotes metastasis, and it can activate the epithelial-mesenchymal transition pathway [3]. In esophageal squamous cell carcinoma, SERPINE2 knockdown inhibits tumor cell invasion and metastasis by inducing epithelial-mesenchymal transition through downregulating BMP4 [5]. In urothelial carcinoma, high SERPINE2 expression is associated with adverse pathologic features and poor prognosis [6]. In hepatoblastoma, SERPINE2 overexpression promotes cell migration, invasion, and suppresses apoptosis, and its upregulation is related to poor prognosis [10]. In oral squamous cell carcinoma, SERPINE2 promotes angiogenesis and lymphangiogenesis, and is an independent poor prognostic factor [9]. In human papillary thyroid carcinoma, SERPINE2 forms a positive feedback with EGF/EGFR to regulate cell proliferation, invasion and migration [8].
In conclusion, Serpine2 plays significant roles in multiple biological processes, especially in cancer-related functions such as tumor metastasis, radioresistance, and cell-cycle-related DNA repair. The use of gene knockout or knockdown models in various cancer types has provided crucial insights into Serpine2's functions, suggesting it could be a potential therapeutic target in these diseases. Additionally, in inner ear research, overexpression of Serpine2 promotes hair cell regeneration, indicating its role in tissue repair and regeneration [7].
References:
1. Zhang, Jingjing, Wu, Qiong, Zhu, Lucheng, Ma, Shenglin, Zhang, Shirong. 2021. SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer. In Cancer letters, 524, 268-283. doi:10.1016/j.canlet.2021.10.001. https://pubmed.ncbi.nlm.nih.gov/34648881/
2. Zhang, Shiyu, Jia, Xing, Dai, Haojiang, Zheng, Shusen, Song, Penghong. 2024. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation. In Cancer communications (London, England), 44, 384-407. doi:10.1002/cac2.12527. https://pubmed.ncbi.nlm.nih.gov/38407942/
3. Chen, Wen-Jin, Dong, Ke-Qin, Pan, Xiu-Wu, Rini, Brian, Cui, Xin-Gang. 2023. Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma. In Cell death & disease, 14, 30. doi:10.1038/s41419-023-05566-w. https://pubmed.ncbi.nlm.nih.gov/36646679/
4. Monard, Denis. 2016. SERPINE2/Protease Nexin-1 in vivo multiple functions: Does the puzzle make sense? In Seminars in cell & developmental biology, 62, 160-169. doi:10.1016/j.semcdb.2016.08.012. https://pubmed.ncbi.nlm.nih.gov/27545616/
5. Zhang, Jianglan, Luo, Aiping, Huang, Furong, Gong, Tongyang, Liu, Zhihua. 2019. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. In Cancer letters, 469, 390-398. doi:10.1016/j.canlet.2019.11.011. https://pubmed.ncbi.nlm.nih.gov/31730904/
6. Chuang, Hao-Wen, Hsia, Kan-Tai, Liao, Jia-Bin, Kuo, Wei-Ting, Yang, Yi-Fang. 2021. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma. In Diagnostics (Basel, Switzerland), 11, . doi:10.3390/diagnostics11101928. https://pubmed.ncbi.nlm.nih.gov/34679626/
7. Sun, Qiuhan, Tan, Fangzhi, Wang, Xinlin, Qi, Jieyu, Chai, Renjie. 2024. AAV-regulated Serpine2 overexpression promotes hair cell regeneration. In Molecular therapy. Nucleic acids, 35, 102396. doi:10.1016/j.omtn.2024.102396. https://pubmed.ncbi.nlm.nih.gov/39687341/
8. Chu, Huimin, Hu, Bo, Su, Xinyu. 2021. SERPINE2 feedback regulates EGF/EGFR signaling in human papillary thyroid carcinoma cells. In Molecular medicine reports, 23, . doi:10.3892/mmr.2021.11981. https://pubmed.ncbi.nlm.nih.gov/33760135/
9. Sasahira, Tomonori, Kurihara-Shimomura, Miyako, Shimomura, Hiroyuki, Kirita, Tadaaki. 2021. SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis. In International journal of clinical oncology, 26, 1831-1839. doi:10.1007/s10147-021-01970-4. https://pubmed.ncbi.nlm.nih.gov/34173120/
10. Zou, Guoyou, Lv, Yong, Kong, Meng, Xiang, Bo, Chen, Jing. 2022. Upregulation of SERPINE2 Results in Poor Prognosis of Hepatoblastoma via Promoting Invasion Abilities. In Disease markers, 2022, 2283541. doi:10.1155/2022/2283541. https://pubmed.ncbi.nlm.nih.gov/36505099/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
